60 Degrees Pharmaceuticals, Inc. Board of Directors

60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal pneumonias, and candidiasis disease; and Celgosivir for respiratory viruses and dengue. The company was founded in 2010 and is headquartered in Washington, the District of Columbia.

Dr. Geoffrey Stuart Dow

Dr. Geoffrey Stuart Dow

Chairman, CEO & President

Dr. Bryan Smith

Dr. Bryan Smith

Chief Medical Officer

Ms. Kristen Landon

Ms. Kristen Landon

Chief Commercial Officer

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.